Ista Vitrase Launch Set For Early 2005 With Approval Of Smaller Vial Size
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Vitrase launch set for early 2005 with approval of smaller vial size. Ista plans to differentiate the spreading agent based on preservative-free formulation and 200 unit/mL vial size. The company remains in discussions with FDA about “approvable” letter for vitreous hemorrhage indication